ArticleInflammatory bowel diseases2021

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.

Sare Verstockt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.